Efficacy of probiotics in Helicobacter pylori eradication therapy

Turkish Journal of Gastroenterology

Volumn 21, Issue 3, 2010, Pages 212-217

  Yaşar, Bülent ^a   Abut, Evren ^b   Kayadibi, Hüseyin ^c   Toros, Burak ^d   Sezikli, Mesut ^a   Akkan, Züleyha ^a   Keskin, Özcan ^c   Övünç Kurdaş, Oya ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b Istanbul Erdem Hospital   (Turkey)

^c Ardahan Military Hospital Turkey   (Turkey)

^d ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Eradication; Helicobacter pylori; Probiotic containing yogurt; Triple therapy

Indexed keywords

AMOXICILLIN; CARBON 13; CLARITHROMYCIN; PANTOPRAZOLE; PLACEBO; PROBIOTIC AGENT; YOGHURT;

ABDOMINAL PAIN; ADD ON THERAPY; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BIFIDOBACTERIUM; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; ERADICATION THERAPY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NONHUMAN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STOMACH BIOPSY; STOMATITIS; TASTE DISORDER; TREATMENT DURATION; UREA BREATH TEST; VOMITING;

ADULT; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; PROBIOTICS; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS;

EID: 77957675696     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2010.0090     Document Type: Article

References (28)

1. Go MF, Crowe SE. Virulence and pathogenicity of Helicobacter pylori. Gastroenterol Clin North Am 2000; 29: 649-70.
2. Eslick GD, Lim LL, Byles JE, et al. Association of Helicobacter pylori infection with gastric carcinoma: a metaanalysis. Am J Gastroenterol 1999; 94(9): 2373-9.
3. Kearney DJ. Retreatment of Helicobacter pylori infection after initial treatment failure. Am J Gastroenterol 2001; 96: 1335-9.
4. Suerbaum S, Michetti P. Medical progress: Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-86.
5. Malfertheine P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-81.
6. Lessbros-Pantoflickova D, Corthesy-Theulaz I, Blum AL. Helicobacter pylori and probiotics. J Nutr 2007; 137: 812-8.
7. Canducci F, Cremonini F, Armuzzi A, et al. Probiotics and Helicobacter pylori eradication. Dig Liver Dis 2002; 34: 81-3.
8. Kim MN, Kim N, Lee SH, et al. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Helicobacter 2008; 13: 261-8.
9. Nista EC, Candelli M, Cremonini F, et al. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther 2004; 20: 1181-8.
10. Cindoruk M, Erkan G, Karakan T, et al. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study. Helicobacter 2007; 12: 309-16.
11. Gumurdulu Y, Serin E, Ozer B, et al. Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. World J Gastroenterol 2004; 10: 668-71.
12. Aydin A, Onder GF, Akarca US, et al. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycin-resistant and -sensitive cases. Turk J Gastroenterol 2005; 16: 203-6.
13. Baglan PH, Bozdayi G, Ozkan M, et al. Clarithromycin resistance prevalence and Icea gene status in Helicobacter pylori clinical isolates in Turkish patients with duodenal ulcer and functional dyspepsia. J Microbiol 2006; 44: 409-16.
14. Kearney DJ. Retreatment of H. pylori infection after initial treatment failure. Am J Gastroenterol 2001; 96: 1335-9.
15. Pantoflickova D, Corthesy-Theulaz I, Dorta G, et al. Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis. Aliment Pharmacol Ther 2003; 18: 805-13.
16. Wang KY, Li SN, Liu CS, et al. Effects of ingesting Lactobacillus and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 2004; 80: 737-41.
17. Gotteland M, Poliak L, Cruchet S, et al. Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus in children colonised by Helicobacter pylori. Acta Paediatr 2005; 94: 1747-51.
18. Wendakoon CN, Thomson ABR, Ozimek L. Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori. Digestion 2002; 65: 16-20.
19. Cats A, Kuipers EJ, Boschaert MA, et al. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Aliment Pharmacol Ther 2003; 17: 429-35.
20. Sheu BS, Wu JJ, Lo CY, et al. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002; 16: 1669-75.
21. Armuzzi A, Cremonini F, Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001; 63: 1-7. (Pubitemid 32098452)
22. Felley C. Probiotics and Helicobacter pylori. Best Pract Res Clin Gastroenterol 2003; 17: 785-91.
23. Fontham ETH, Ruiz B, Perez A, et al. Determinants of Helicobacter pylori infection and chronic gastritis. Am J Gastroenterol 1995; 90: 1094-101.
24. Picard J, Fiaramonti J, Francois A, et al. Review article: Bifidobacteria as probiotic agents-physiological effects and clinical benefits. Aliment Pharmacol Ther 2005; 22: 495-512.
25. Lewis SJ, Freedman AR. Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 1998; 12: 807-22.
26. Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side-effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002; 97: 2744-9.
27. Canducci F, Armuzzi A, Cremonini F, et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 2000; 14: 1625-9.
28. Huebner ES, Surawicz CM. Probiotics in the prevention and treatment of gastrointestinal infections. Gastroenterol Clin North Am 2006; 35: 355-65.